The role of fluorine-18-fluorodeoxyglucose positron emission tomography in evaluating the response to tyrosine-kinase inhibitors in patients with metastatic primary renal cell carcinoma
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Carmelo Caldarella
Institute of Nuclear Medicine, PET/CT Center, Catholic University, Rome, Italy
Institute of Nuclear Medicine, PET/CT Center, Department of Bioimaging and Radiological Sciences, Catholic University, Largo Gemelli 8, 00168 Rome, Italy
Barbara Muoio
School of Medicine, Catholic University, Rome, Italy
Maria Antonietta Isgrò
Institute of Biochemistry and Clinical Biochemistry, Catholic University, Rome, Italy
Emilio Porfiri
School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom
Giorgio Treglia
Department of Nuclear Medicine and PET/CT Center, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Luca Giovanella
Department of Nuclear Medicine and PET/CT Center, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland